Smiths Group (SMGZY)
(Delayed Data from OTC)
$22.58 USD
+0.08 (0.38%)
Updated Jul 24, 2024 03:53 PM ET
2-Buy of 5 2
B Value B Growth D Momentum A VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
SMGZY 22.58 +0.08(0.38%)
Will SMGZY be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for SMGZY based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for SMGZY
SMGZY vs. AMPL: Which Stock Is the Better Value Option?
SMGZY vs. PLTR: Which Stock Should Value Investors Buy Now?
SMGZY: What are Zacks experts saying now?
Zacks Private Portfolio Services
SMGZY or TRI: Which Is the Better Value Stock Right Now?
SMGZY or TRI: Which Is the Better Value Stock Right Now?
SMGZY or CLMB: Which Is the Better Value Stock Right Now?
Other News for SMGZY
IN BRIEF: Smiths Group banks USD152 million from ICU Medical shares
ICU Medical - Stabilization Is In Sight, But The Road Back Is Difficult
TOP NEWS: Smiths Group reports 7.7% revenue growth in past nine months
GET READY: Cranswick, Kingfisher, Pennon, Smiths Group at 0700 BST
GLOBAL BRIEFING: Stocks to pull back after mixed close on Wall St